YALE UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1701-10-09
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.yale.edu
SILVER-AMI: Outcomes in Older Persons With Heart Attacks
Completed
- Conditions
- Acute Myocardial Infarction
- First Posted Date
- 2012-12-21
- Last Posted Date
- 2019-05-28
- Lead Sponsor
- Yale University
- Target Recruit Count
- 3042
- Registration Number
- NCT01755052
- Locations
- 🇺🇸
Meritus Medical Center, Hagerstown, Maryland, United States
🇺🇸Mission Medical Associates, Inc. dba Asheville Cardiology Associates, Asheville, North Carolina, United States
🇺🇸Emory University, Atlanta, Georgia, United States
3-D Imaging Assessment of Scar Formation and Would Healing in Fat Grafted vs Non-Fat Grafted Facial Reconstruction Wound Sites
Phase 1
Withdrawn
- Conditions
- Scar FormationAutologous Fat Grafting
- Interventions
- Procedure: Autologous Fat GraftingOther: No intervention
- First Posted Date
- 2012-12-17
- Last Posted Date
- 2016-09-05
- Lead Sponsor
- Yale University
- Registration Number
- NCT01750424
- Locations
- 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
A Comparative Study of Occlusive Heat Patch in the Treatment of Warts
Not Applicable
Completed
- Conditions
- Verruca (Warts)
- Interventions
- Device: Occlusive Heat Patch
- First Posted Date
- 2012-12-10
- Last Posted Date
- 2022-11-15
- Lead Sponsor
- Yale University
- Target Recruit Count
- 73
- Registration Number
- NCT01746056
- Locations
- 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States
An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study)
Phase 1
Terminated
- Conditions
- Mature T-cell LymphomaMultiple MyelomaHodgkin's Lymphoma
- Interventions
- First Posted Date
- 2012-12-05
- Last Posted Date
- 2020-03-04
- Lead Sponsor
- Yale University
- Target Recruit Count
- 12
- Registration Number
- NCT01742793
- Locations
- 🇺🇸
Yale Cancer Center, New Haven, Connecticut, United States
Does Doxazosin Attenuate Stress-induced Smoking and Improve Clinical Outcomes?
Phase 2
Completed
- Conditions
- Smoking
- Interventions
- First Posted Date
- 2012-11-21
- Last Posted Date
- 2018-02-20
- Lead Sponsor
- Yale University
- Target Recruit Count
- 35
- Registration Number
- NCT01730846
- Locations
- 🇺🇸
Yale Center for Clinical Investigations, Yale University, New Haven, Connecticut, United States
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Recruiting
- Conditions
- SchizophreniaPost Traumatic Stress DisorderCannabis DependenceProdromal for Psychotic IllnessOpioid-use DisorderFamily History of AlcoholismHealthy Control
- Interventions
- Radiation: [11-C]OMAR
- First Posted Date
- 2012-11-21
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Yale University
- Target Recruit Count
- 100
- Registration Number
- NCT01730781
- Locations
- 🇺🇸
Connecticut Mental Health Center, Clinical Neuroscience Research Unit, New Haven, Connecticut, United States
Hepatic De Novo Lipogenesis (DNL)in the Pathogenesis of Hepatic Steatosis in Obese Youth
Completed
- Conditions
- Fatty LiverHepatic Steatosis
- First Posted Date
- 2012-11-12
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Yale University
- Target Recruit Count
- 60
- Registration Number
- NCT01725035
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
Decreasing Stress and Improving Self-control With "Stress in Control" (Sync) Training
Phase 1
Completed
- Conditions
- StressObesityOvereating
- Interventions
- Behavioral: Nutritional CounselingBehavioral: Mindfulness Intervention
- First Posted Date
- 2012-11-04
- Last Posted Date
- 2015-07-30
- Lead Sponsor
- Yale University
- Target Recruit Count
- 112
- Registration Number
- NCT01721499
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
Open-Trial of EPI-743 for Adults With Tourette Syndrome
Phase 1
Completed
- Conditions
- Tourette Syndrome
- Interventions
- Drug: EPI-743
- First Posted Date
- 2012-11-01
- Last Posted Date
- 2014-03-05
- Lead Sponsor
- Yale University
- Target Recruit Count
- 10
- Registration Number
- NCT01719523
- Locations
- 🇺🇸
Yale Child Study Center, New Haven, Connecticut, United States
Norepinephrine Transporter Imaging in Addiction Disorders
Withdrawn
- Conditions
- Alcohol DependenceObesity
- Interventions
- Drug: (S,S)-[11C]MRB
- First Posted Date
- 2012-11-01
- Last Posted Date
- 2023-03-02
- Lead Sponsor
- Yale University
- Registration Number
- NCT01719458
- Locations
- 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
© Copyright 2025. All Rights Reserved by MedPath